Moghe S , Jiang F , Miura Y , Cerny RL , Tsai MY , Furukawa M .

	Fig. 1. CUL3 functions in mitotic progression.(A) Asynchronous HeLa and U2OS cells were transfected with indicated siRNAs. 72 hours after transfection, cell cycle profile was analyzed by flow cytometry, and (B) cell lysate was analyzed by western blotting (WB) with anti-CUL3 or anti-GAPDH (control). (C) Histone H2B-GFP stably expressing HeLa cells were transfected with either control or CUL3 siRNAs. 48h after transfection, cells were analyzed by time-lapse antibodies fluorescence microscopy. One representative cell for control and CUL3 RNAi is shown from chromosome condensation (0 min). Scale bars, 10 μm.
	Fig. 2. CUL3 functions in mitotic entry.(A) A schematic protocol for cell synchronization (by double thymidine block) and RNAi. (B, C, D) U2OS cells were synchronized and transfected as indicated and subjected to the protocol shown in (A) with indicated siRNAs. (B) Phase pictures of indicated siRNA transfected cells at 8 hours after release. Scale bars, 100 μm. (C) When released from 2nd thymidine block, cells were lysed and subjected to WB with indicated antibodies. (D) Cells were fixed and stained with DAPI at the indicated times after release. Over 500 cells were analyzed and mitotic index was determined.
	Fig. 3. CUL3 localizes at centrosomes and the mitotic spindle(A) U2OS cells were fixed with paraformaldehyde (top panels) or methanol (bottom panels) and immunostained with indicated antibodies. DNA was counter-stained by DAPI. Representative pictures of cells in late G2 phase (Interphase), prophase, prometaphase, and metaphase are shown. White arrowheads indicate colocalization of α-tubulin or γ-tubulin and CUL3 in interphase and propahse. Scale bars, 10 μm. (B) Whole cell extract and purified centrosomes from U2OS cells were subjected to WB with indicated antibodies.
	Fig. 4. CUL3 and KLHL18 knockdown cells have delayed mitotic entry but progress through S phase normally(A) U2OS cells were synchronized and transfected with indicated siRNAs as shown in Fig. 2A. Cells were fixed and stained with DAPI at the indicated times after release. Over 500 cells were analyzed and the mitotic index was determined, data are represented as mean ± SD. (B, C) U2OS cells were synchronized and transfected as indicated in Fig. 2A. (B) At the indicated times following release cells were pulse labeled with 10uM BrdU for 2 hours and stained with anti-BrdU-FITC and 7-AAD, and analyzed by flow cytometry. The percentages of incorporated BrdU are indicated. (C) Lysates from the indicated time points after release were analyzed by WB with indicated antibodies. Lysates from U2OS cells treated with UV were used as a positive control for phospho-Chk1 blot.
	Fig. 5. KLHL18 interacts with CUL3.(A) Schematic figure of wild type and mutant of KLHL18. (B) FLAG-tagged KLHL18 expressing plasmids were transfected to HeLa cells and treated with 100 ng/mL Nocodazole for 12 hours before lysis. FLAG KLHL18 and endogenous CUL3 interaction was examined by immunoprecipitation (IP) and WB with indicated antibodies. (C) Wild type and mutant KLHL18 and CUL3 expressing plasmids were transfected to HeLa cells. Interactions were examined by IP-WB analysis with indicated antibodies. (D) Endogenous CUL3 and KLHL18 interaction in U2OS cells was examined by IP-WB with indicated antibodies
	Fig. 6. The CUL3-KLHL18 ligase is involved in Aurora-A activation at the centrosomesU2OS cells were synchronized and transfected with indicated siRNAs according to the protocol in Fig. 2A. (A) Cells were lysed at the indicated times after release and examined by WB with indicated antibodies. (B, C) Cells were fixed at 10 hours after release and immunostained with indicated antibodies. DNA was counter-stained by DAPI. Representative pictures of cells in prophase are shown. White arrowheads indicate colocalization of γ-tubulin and Aurora-A T288-P or γ-tubulin and Aurora-A. Scale bars, 10 μm. (D, E) Colocalization of γ-tubulin and Aurora-A T288-P (D) and γ-tubulin and Aurora-A (E) in more than 50 of each siRNA transfected prophase cells were quantified.
	Fig. 7. KLHL18 interacts with Aurora-A directly.(A) U2OS cells treated with 100 ng/mL Nocodazole for 12 hours were lysed and examined by IP-WB with indicated antibodies. (B) CSF-arrested Xenopus egg extracts were examined by IP-WB analysis with indicated antibodies. Asterisk shows non-specific band. (C) FLAG-tagged KLHL18 and Myc-tagged Aurora-A (Myc-Aur-A) expressing plasmids were co-transfected to 293T cells and their interactions were determined by IP-WB analysis with indicated antibodies. (D) FLAG-tagged KLHL18 expressing plasmid was transfected to 293T cells and the FLAG-KLHL18 and endogenous Aurora-A interaction was determined by IP-WB with indicated antibodies. (E) Bacterially expressed and purified GST fused KLHL18 or GST and 6x Histidine fused (His-) Aurora-A were incubated in vitro as indicated and their interactions were determined by GST-pull down assay. The input and GST-pull down reactions were separated by SDS-PAGE, transferred to a nitrocellulose membrane and examined by Ponceau S staining (upper panel). His-Aurora-A was examined by WB with anti-Aurora-A antibody as well (bottom panel).
	Fig. 8. The CUL3-KLHL18 ligase ubiquitylates Aurora-A in vivo and in vitro.(A, B) FLAG-tagged Aurora-A (A) or Myc-tagged Aurora-A deleted C-terminal D-box (Aur-AΔD) (B) were cotransfected with Myc-tagged or FLAG-tagged CUL3, Myc-tagged or FLAG-tagged KLHL18, and HA-tagged Ubiquitin expressing plasmids to 293T cells as indicated. Twenty four hours after transfection, cells were lysed with a 1% SDS containing lysis buffer and boiled for 15 min. Denatured lysates were then diluted with 0.5% NP-40 lysis buffer and IP with anti-FLAG (A) or anti-Myc (B) antibody. The washed immunoprecipitates and the total cell lysate (input) were resolved by SDS-PAGE, followed by WB with indicated antibodies. (C) CUL3-KLHL18-ROC1 complexes were prepared from triply transfected 293T cells by IP using anti-FLAG antibody and used as the source of E3 ligase. (D) Bacterially expressed and purified His-tagged Aurora-A (His-Aur-A) (Fig. 6E) was incubated with the KLHL18-CUL3-ROC1 E3 complex (C), E1, E2, HA-tagged ubiquitin (HA-Ub), and ATP. The reactions were immunoprecipitated with anti-HA antibody and blotted with anti-Aurora-A antibody to examine Aurora-A ubiquitylation.

Bennett, Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. 2010, Pubmed

Bennett, Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. 2010, Pubmed
Cassimeris, TOGp, the human homolog of XMAP215/Dis1, is required for centrosome integrity, spindle pole organization, and bipolar spindle assembly. 2004, Pubmed
Crane, Requirements for the destruction of human Aurora-A. 2004, Pubmed , Xenbase
Cummings, The Cul3/Klhdc5 E3 ligase regulates p60/katanin and is required for normal mitosis in mammalian cells. 2009, Pubmed
De Luca, A functional interplay between Aurora-A, Plk1 and TPX2 at spindle poles: Plk1 controls centrosomal localization of Aurora-A and TPX2 spindle association. 2006, Pubmed
Eyers, A novel mechanism for activation of the protein kinase Aurora A. 2003, Pubmed , Xenbase
Fujiyama-Nakamura, BTB protein, dKLHL18/CG3571, serves as an adaptor subunit for a dCul3 ubiquitin ligase complex. 2009, Pubmed
Fukuda, Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. 2005, Pubmed
Furukawa, BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. 2005, Pubmed
Furukawa, Activation of UBC5 ubiquitin-conjugating enzyme by the RING finger of ROC1 and assembly of active ubiquitin ligases by all cullins. 2002, Pubmed
Furukawa, Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases. 2003, Pubmed
Furukawa, Assays for RING family ubiquitin ligases. 2005, Pubmed
Geyer, BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. 2003, Pubmed
Hansen, Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1. 2004, Pubmed , Xenbase
Hershko, The ubiquitin system. 1998, Pubmed
Hirota, Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. 2003, Pubmed , Xenbase
Joukov, Centrosomal protein of 192 kDa (Cep192) promotes centrosome-driven spindle assembly by engaging in organelle-specific Aurora A activation. 2010, Pubmed , Xenbase
Kardon, Regulators of the cytoplasmic dynein motor. 2009, Pubmed
Katayama, Interaction and feedback regulation between STK15/BTAK/Aurora-A kinase and protein phosphatase 1 through mitotic cell division cycle. 2001, Pubmed
Kayser, Defining parameters for homology-tolerant database searching. 2004, Pubmed
Kobayashi, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. 2004, Pubmed
Littlepage, Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. 2002, Pubmed , Xenbase
Lénárt, The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. 2007, Pubmed
Macůrek, Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. 2008, Pubmed
Maerki, The Cul3-KLHL21 E3 ubiquitin ligase targets aurora B to midzone microtubules in anaphase and is required for cytokinesis. 2009, Pubmed
Marumoto, Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. 2003, Pubmed , Xenbase
Marumoto, Aurora-A - a guardian of poles. 2005, Pubmed , Xenbase
McEvoy, Constitutive turnover of cyclin E by Cul3 maintains quiescence. 2007, Pubmed
Mitchison, Isolation of mammalian centrosomes. 1986, Pubmed
Molli, Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A. 2010, Pubmed
Murray, Recycling the cell cycle: cyclins revisited. 2004, Pubmed
Petroski, Function and regulation of cullin-RING ubiquitin ligases. 2005, Pubmed
Pintard, The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. 2003, Pubmed
Pugacheva, The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome. 2005, Pubmed
Sabino, Drosophila Ajuba is not an Aurora-A activator but is required to maintain Aurora-A at the centrosome. 2011, Pubmed
Seki, Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry. 2008, Pubmed , Xenbase
Singer, Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. 1999, Pubmed
Sumara, A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells. 2007, Pubmed
Telford, Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. 1991, Pubmed
Tsai, A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. 2003, Pubmed , Xenbase
Walter, The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. 2000, Pubmed
Xu, BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. 2003, Pubmed